Zatravkin S N, Vishlenkova E A, Ignatiev V G
N. A. Semashko National Research Institute of Public Health, 105064, Moscow, Russia,
Forschungsinstitut, Deutsches Museum von Meisterwerken der Naturwissenschaft und Technik, Munchen, Deutschland.
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2022 May;30(3):503-507. doi: 10.32687/0869-866X-2022-30-3-503-507.
The third report, which is a continuation of article on the Russian pharmaceutical branch in the 1990s, analyses corresponding conceptions of internal observers (participators of production and distribution of medications), including their assessments of normality of emerging market. The conclusion is made that the Russian pharmaceutical market grew from chaos that resulted from wreckage of the Soviet medication supply system in 1994-1998. The general dominance of generics over patented medications, distributors over manufacturers, weak interest of state authorities to long-term cooperation with pharmaceutics for the sake of development of own national production, low legal culture were generic characteristics of its infrastructure.
第三份报告是关于20世纪90年代俄罗斯制药分支文章的延续，分析了内部观察者（药品生产和分销参与者）的相应观念，包括他们对新兴市场常态的评估。得出的结论是，俄罗斯药品市场从1994年至1998年苏联药品供应体系崩溃所导致的混乱局面中发展而来。仿制药对专利药品的普遍主导、经销商对制造商的主导、国家当局为发展本国生产而与制药业进行长期合作的兴趣淡薄、法律文化薄弱是其基础设施的一般特征。
